eWEEK content and product recommendations are editorially independent. We may make money when you click on links to our partners. Learn More.
Biostatisticians sometimes must spend hours reorganizing data from various formats. The FDA hopes that its experts and those at drug sponsors can soon use more of that time to actually analyze the data because more data sets will come in a standard format, the study data tabulation model (SDTM) developed by the Clinical Data Interchange Consortium. The standard was announced Wednesday in Washington.
To read more, click here.